ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Detection and monitoring of the BCR-ABL transcripts are essential for CML diagnosis and evaluation of patient's response to treatment with tyrosine kinase inhibitors such as Imatinib [10].